Feedback / Questions
lorigerlimab (MGD019) - MacroGenics
vobramitamab duocarmazine (MGC018) - MacroGenics
http://clinicaltrials.gov/ct2/show/NCT05293496
Jun 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next